Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1990 | 1 |
1997 | 1 |
2003 | 1 |
2004 | 1 |
2005 | 1 |
2007 | 1 |
2021 | 1 |
2023 | 0 |
Search Results
6
results
Results by year
Page 1
Physical activity modulates mononuclear phagocytes in mammary tissue and inhibits tumor growth in mice.
PeerJ. 2021 Jan 19;9:e10725. doi: 10.7717/peerj.10725. eCollection 2021.
PeerJ. 2021.
PMID: 33552733
Free PMC article.
Pharmacokinetic screening of o-naphthoquinone 5-lipoxygenase inhibitors.
Rakhit A, Kuwahara SK, Jones DR, Soliman VF, Kotake AN, Oglesby TD, Wasley JW, Tripp SL, Douglas FL.
Rakhit A, et al. Among authors: soliman vf.
Pharm Res. 1990 Oct;7(10):1071-6. doi: 10.1023/a:1015903519637.
Pharm Res. 1990.
PMID: 2281039
Item in Clipboard
Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.
Harwood HJ Jr, Petras SF, Hoover DJ, Mankowski DC, Soliman VF, Sugarman ED, Hulin B, Kwon Y, Gibbs EM, Mayne JT, Treadway JL.
Harwood HJ Jr, et al. Among authors: soliman vf.
J Lipid Res. 2005 Mar;46(3):547-63. doi: 10.1194/jlr.M400436-JLR200. Epub 2004 Dec 16.
J Lipid Res. 2005.
PMID: 15604516
Free article.
Item in Clipboard
Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation.
Kalgutkar AS, Dalvie DK, Aubrecht J, Smith EB, Coffing SL, Cheung JR, Vage C, Lame ME, Chiang P, McClure KF, Maurer TS, Coelho RV Jr, Soliman VF, Schildknegt K.
Kalgutkar AS, et al. Among authors: soliman vf.
Drug Metab Dispos. 2007 Jun;35(6):848-58. doi: 10.1124/dmd.106.013649. Epub 2007 Mar 7.
Drug Metab Dispos. 2007.
PMID: 17344339
Item in Clipboard
Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
Harwood HJ Jr, Petras SF, Shelly LD, Zaccaro LM, Perry DA, Makowski MR, Hargrove DM, Martin KA, Tracey WR, Chapman JG, Magee WP, Dalvie DK, Soliman VF, Martin WH, Mularski CJ, Eisenbeis SA.
Harwood HJ Jr, et al. Among authors: soliman vf.
J Biol Chem. 2003 Sep 26;278(39):37099-111. doi: 10.1074/jbc.M304481200. Epub 2003 Jul 3.
J Biol Chem. 2003.
PMID: 12842871
Free article.
Item in Clipboard
Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C, Soliman V.
Prakash C, et al. Among authors: soliman v.
Drug Metab Dispos. 1997 Nov;25(11):1288-97.
Drug Metab Dispos. 1997.
PMID: 9351906
Item in Clipboard
Cite
Cite